Idit Bloch

Idit Bloch

Auto-generated profile, based on publicly available information

Idit Bloch

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada and Hadassah Medical School, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2021 in NAR Genomics and Bioinformatics
Verified
Journal Article
Open access
PDF file
TTTomer Tsaban
Tomer Tsaban
DSDoron Stupp
Doron Stupp
DSDana Sherill-Rofe
Dana Sherill-Rofe
IBIdit Bloch
Idit Bloch
ESElad Sharon
Elad Sharon
YTYuval Tabach
Yuval Tabach
Mapping co-evolved genes via phylogenetic profiling (PP) is a powerful approach to uncover functional interactions between genes and to associate them with pathways. Despite many successful endeavors, the understanding of co-evolutionary signals in eukaryotes remains partial. Our hypothesis is that ‘Clades’, branches of the tree of life (e.g. primates and mammals), encompass signals that cannot be detected by PP using all eukaryotes. As such, integrating information from different clades should reveal local co-evolution signals and improve function prediction. Accordingly, we analyzed 1028 genomes in 66 clades and demonstrated that the co-evolutionary signal was scattered across clades. We showed that functionally related genes are frequently co-evolved in only parts of the eukaryotic tree and that clades are complementary in detecting functional interactions within pathways. We examined the non-homologous end joining pathway and the UFM1 ubiquitin-like protein pathway and showed that both demonstrated distinguished co-evolution patterns in specific clades. Our research offers a different way to look at co-evolution across eukaryotes and points to the importance of modular co-evolution analysis. We developed the ‘CladeOScope’ PP method to integrate information from 16 clades across over 1000 eukaryotic genomes and is accessible via an easy to use web server at http://cladeoscope.cs.huji.ac.il.

30 April 2020 in Bioinformatics
Verified
Journal Article
Closed access
IBIdit Bloch
Idit Bloch
DSDana Sherill-Rofe
Dana Sherill-Rofe
DSDoron Stupp
Doron Stupp
IUIrene Unterman
Irene Unterman
HBHodaya Beer
Hodaya Beer
YTYuval Tabach
Yuval Tabach
Summary: The exponential growth in available genomic data is expected to reach full sequencing of a million genomes in the coming decade. Improving and developing methods to analyze these genomes and to reveal their utility is of major interest in a wide variety of fields, such as comparative and functional genomics, evolution and bioinformatics. Phylogenetic profiling is an established method for predicting functional interactions between proteins based on similarities in their evolutionary patterns across species. Proteins that function together (i.e. generate complexes, interact in the same pathways or improve adaptation to environmental niches) tend to show coordinated evolution across the tree of life. The normalized phylogenetic profiling (NPP) method takes into account minute changes in proteins across species to identify protein co-evolution. Despite the success of this method, it is still not clear what set of parameters is required for optimal use of co-evolution in predicting functional interactions. Moreover, it is not clear if pathway evolution or function should direct parameter choice. Here, we create a reliable and usable NPP construction pipeline. We explore the effect of parameter selection on functional interaction prediction using NPP from 1028 genomes, both separately and in various value combinations. We identify several parameter sets that optimize performance for pathways with certain biological annotation. This work reveals the importance of choosing the right parameters for optimized function prediction based on a biological context. Availability and implementation: Source code and documentation are available on GitHub: https://github.com/iditam/CompareNPPs. Contact: yuvaltab@ekmd.huji.ac.il Supplementary information: Supplementary data are available at Bioinformatics online.

11 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMyriam Maoz
Myriam Maoz
MDMichal Devir
Michal Devir
MIMichal Inbar
Michal Inbar
ZIZiva Inbar-Daniel
Ziva Inbar-Daniel
DSDana Sherill-Rofe
Dana Sherill-Rofe
AZAviad Zick
Aviad Zick
ERBB2 amplification is a prognostic marker for aggressive tumors and a predictive marker for prolonged survival following treatment with HER2 inhibitors. We attempt to sub-group HER2+ tumors based on amplicon structures and co-amplified genes. We examined five HER2+ cell lines, three HER2+ xenographs and 57 HER2+ tumor tissues. ERBB2 amplification was analyzed using digital droplet PCR and low coverage whole genome sequencing. In some HER2+ tumors PPM1D, that encodes WIP1, is co-amplified. Cell lines were treated with HER2 and WIP1 inhibitors. We find that inverted duplication is the amplicon structure in the majority of HER2+ tumors. In patients suffering from an early stage disease the ERBB2 amplicon is composed of a single segment while in patients suffering from advanced cancer the amplicon is composed of several different segments. We find robust WIP1 inhibition in some HER2+ PPM1D amplified cell lines. Sub-grouping HER2+ tumors using low coverage whole genome sequencing identifies inverted duplications as the main amplicon structure and based on the number of segments, differentiates between local and advanced tumors. In addition, we found that we could determine if a tumor is a recurrent tumor or second primary tumor and identify co-amplified oncogenes that may serve as targets for therapy.